Cannabielsoin, also known as CBE, is a non-psychoactive cannabis cannabinoid. CBE was first mentioned in 1973 in scientific journals. Many research studies were conducted to determine the structure of CBE. CBE is non-psychoactive and was created from cannabidiol.
Notably, CBE is not listed under the UN Conventions. Although not much information is available about the benefits of CBE, scientists and researchers believe that CBE may have an entourage effect. According to the entourage effect theory, CBE can be used in combination with flavonoids and other cannabinoids to create a synergistic effect which can lead to health benefits. CBE, like CBD, can provide health benefits, just as CBD.